Low-rate repetitive TMS allays central pain.
Only about 50% of central pain patients respond to motor cortex stimulation in the long run. There is a need for prognostic factors. Here we show that propofol test and TMS both predict short-term effect in nine patients with central pain. This may help reduce the number of failures.
Canavero
S
S
Pain Relief Unit, Department of Neurosciences, Molinette Hospital, Turin, Italy. solara@infinito.it
Bonicalzi
V
V
Dotta
M
M
Vighetti
S
S
Asteggiano
G
G
D000328:Adult; D000368:Aged; D004599:Electric Stimulation Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives; D008280:Magnetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009044:Motor Cortex / Q000502:physiology*; D010146:Pain / Q000175:diagnosis; D059408:Pain Management; D010865:Pilot Projects; D011237:Predictive Value of Tests; D015742:Propofol
D006993:Hypnotics and Sedatives; D015742:Propofol